CytRx Corporation (CYTR)

2.42 +0.00  +0.00%  May 21, 8:00PM
Add to Watchlists Create an Alert

CytRx Corporation SG&A Expense Quarterly:

2.617M for Dec. 31, 2012
View Full Chart

CytRx Corporation SG&A Expense Quarterly Chart

    CytRx Corporation Historical SG&A Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 2.617M
    Sept. 30, 2012 1.730M
    June 30, 2012 2.092M
    March 31, 2012 1.915M
    Dec. 31, 2011 1.404M
    Sept. 30, 2011 1.739M
    June 30, 2011 2.027M
    March 31, 2011 2.050M
    Dec. 31, 2010 1.683M
    Sept. 30, 2010 1.848M
    June 30, 2010 2.060M
    March 31, 2010 2.645M
    Dec. 31, 2009 2.140M
    Sept. 30, 2009 2.576M
    June 30, 2009 1.928M
    March 31, 2009 2.483M
    Dec. 31, 2008 1.666M
    Sept. 30, 2008 1.601M
    June 30, 2008 3.192M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
       
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro
    Sept. 30, 2000 Go Pro

    About SG&A Expense

    SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

    The details of how SG&A expenses are calculated vary widely from company to company, so YCharts recommends looking at the annual report (10-k) an investor is interested in dissecting this number further.
    Learn More

    Get data for

    CYTR SG&A Expense Quarterly Benchmarks

    Companies
    Seattle Genetics 23.41M
    Celldex Therapeutics 3.138M
    ImmunoCellular Therapeutics 1.085M

    CYTR SG&A Expense Quarterly Rankings

    Overall 49th percentile
    4034 of 8005
    Sector 38th percentile
    424 of 686 in Healthcare
    Industry 49th percentile
    125 of 248 in Biotechnology

    CYTR SG&A Expense Quarterly Range, Past 5 Years

    Minimum 1.404M Dec 2011
    Maximum 3.192M Jun 2008
    Average 2.073M